Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard who wrote (48)	8/14/1997 9:19:00 AM
From: Frac	of 569

Howard: Thanks for the background. This has been in Canada for a few years and very little sales resulted because of the reimbursement problem by Canada's National Med plan. As you must know by now, BIOX got FDA approval to market SYNVISC yesterday. That's the reason for the $3 move. News release vague as to potential sales $ and profits. They do have the top marketing firm in the US for these products.As of now, it is all promise. The point on Rheumatologists answers one of my main questions. I know orthopods will be reluctant to give up total knees etc. if they can't get adequate compensation for an alternative treatment.I still have not seen any earnings est.. BIOX will get a $10 or $12 million progress payment because of this approval. So next quarter's earnings will be fat with fees but not sales. Ron

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next